nodes	percent_of_prediction	percent_of_DWPC	metapath
Metoprolol—ABCB1—Dactinomycin—sarcoma	0.121	0.262	CbGbCtD
Metoprolol—ABCB1—Mitoxantrone—sarcoma	0.108	0.234	CbGbCtD
Metoprolol—ABCB1—Vincristine—sarcoma	0.0746	0.161	CbGbCtD
Metoprolol—ABCB1—Etoposide—sarcoma	0.0683	0.148	CbGbCtD
Metoprolol—ABCB1—Doxorubicin—sarcoma	0.0466	0.101	CbGbCtD
Metoprolol—CYP2D6—Doxorubicin—sarcoma	0.0439	0.0949	CbGbCtD
Metoprolol—Cardiac arrest—Epirubicin—sarcoma	0.00104	0.00194	CcSEcCtD
Metoprolol—Hypoglycaemia—Doxorubicin—sarcoma	0.00104	0.00193	CcSEcCtD
Metoprolol—Cardiac failure—Doxorubicin—sarcoma	0.00104	0.00193	CcSEcCtD
Metoprolol—Mood swings—Epirubicin—sarcoma	0.00104	0.00193	CcSEcCtD
Metoprolol—Paraesthesia—Mitoxantrone—sarcoma	0.00104	0.00193	CcSEcCtD
Metoprolol—Loss of consciousness—Etoposide—sarcoma	0.00103	0.00192	CcSEcCtD
Metoprolol—Cerebrovascular accident—Doxorubicin—sarcoma	0.00103	0.00192	CcSEcCtD
Metoprolol—Dyspnoea—Mitoxantrone—sarcoma	0.00103	0.00192	CcSEcCtD
Metoprolol—Somnolence—Mitoxantrone—sarcoma	0.00103	0.00191	CcSEcCtD
Metoprolol—Gastrointestinal disorder—Vincristine—sarcoma	0.00102	0.0019	CcSEcCtD
Metoprolol—Fatigue—Vincristine—sarcoma	0.00102	0.0019	CcSEcCtD
Metoprolol—Dyspepsia—Mitoxantrone—sarcoma	0.00102	0.00189	CcSEcCtD
Metoprolol—Hypertension—Etoposide—sarcoma	0.00102	0.00189	CcSEcCtD
Metoprolol—Pain—Vincristine—sarcoma	0.00101	0.00189	CcSEcCtD
Metoprolol—Constipation—Vincristine—sarcoma	0.00101	0.00189	CcSEcCtD
Metoprolol—Liver function test abnormal—Epirubicin—sarcoma	0.00101	0.00188	CcSEcCtD
Metoprolol—Chest pain—Etoposide—sarcoma	0.001	0.00186	CcSEcCtD
Metoprolol—Orthostatic hypotension—Epirubicin—sarcoma	0.001	0.00186	CcSEcCtD
Metoprolol—Abdominal pain upper—Epirubicin—sarcoma	0.001	0.00186	CcSEcCtD
Metoprolol—Affect lability—Doxorubicin—sarcoma	0.000997	0.00186	CcSEcCtD
Metoprolol—Fatigue—Mitoxantrone—sarcoma	0.000995	0.00185	CcSEcCtD
Metoprolol—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.000994	0.00185	CcSEcCtD
Metoprolol—Breast disorder—Epirubicin—sarcoma	0.000989	0.00184	CcSEcCtD
Metoprolol—Pain—Mitoxantrone—sarcoma	0.000987	0.00184	CcSEcCtD
Metoprolol—Constipation—Mitoxantrone—sarcoma	0.000987	0.00184	CcSEcCtD
Metoprolol—Hypersensitivity—Thiotepa—sarcoma	0.000984	0.00183	CcSEcCtD
Metoprolol—Hypersensitivity—Dactinomycin—sarcoma	0.000977	0.00182	CcSEcCtD
Metoprolol—Gastrointestinal pain—Vincristine—sarcoma	0.000969	0.0018	CcSEcCtD
Metoprolol—Confusional state—Etoposide—sarcoma	0.000968	0.0018	CcSEcCtD
Metoprolol—Cardiac arrest—Doxorubicin—sarcoma	0.000963	0.00179	CcSEcCtD
Metoprolol—Mood swings—Doxorubicin—sarcoma	0.000959	0.00179	CcSEcCtD
Metoprolol—Asthenia—Thiotepa—sarcoma	0.000959	0.00179	CcSEcCtD
Metoprolol—Asthenia—Dactinomycin—sarcoma	0.000951	0.00177	CcSEcCtD
Metoprolol—Feeling abnormal—Mitoxantrone—sarcoma	0.000951	0.00177	CcSEcCtD
Metoprolol—Pruritus—Thiotepa—sarcoma	0.000945	0.00176	CcSEcCtD
Metoprolol—Gastrointestinal pain—Mitoxantrone—sarcoma	0.000944	0.00176	CcSEcCtD
Metoprolol—Thrombocytopenia—Etoposide—sarcoma	0.00094	0.00175	CcSEcCtD
Metoprolol—Tachycardia—Etoposide—sarcoma	0.000937	0.00174	CcSEcCtD
Metoprolol—Body temperature increased—Vincristine—sarcoma	0.000937	0.00174	CcSEcCtD
Metoprolol—Abdominal pain—Vincristine—sarcoma	0.000937	0.00174	CcSEcCtD
Metoprolol—Liver function test abnormal—Doxorubicin—sarcoma	0.000935	0.00174	CcSEcCtD
Metoprolol—Skin disorder—Etoposide—sarcoma	0.000932	0.00174	CcSEcCtD
Metoprolol—Hyperhidrosis—Etoposide—sarcoma	0.000928	0.00173	CcSEcCtD
Metoprolol—Orthostatic hypotension—Doxorubicin—sarcoma	0.000925	0.00172	CcSEcCtD
Metoprolol—Abdominal pain upper—Doxorubicin—sarcoma	0.000925	0.00172	CcSEcCtD
Metoprolol—Angina pectoris—Epirubicin—sarcoma	0.000922	0.00172	CcSEcCtD
Metoprolol—Urticaria—Mitoxantrone—sarcoma	0.000917	0.00171	CcSEcCtD
Metoprolol—Breast disorder—Doxorubicin—sarcoma	0.000915	0.0017	CcSEcCtD
Metoprolol—Diarrhoea—Thiotepa—sarcoma	0.000914	0.0017	CcSEcCtD
Metoprolol—Abdominal pain—Mitoxantrone—sarcoma	0.000912	0.0017	CcSEcCtD
Metoprolol—Body temperature increased—Mitoxantrone—sarcoma	0.000912	0.0017	CcSEcCtD
Metoprolol—Diarrhoea—Dactinomycin—sarcoma	0.000907	0.00169	CcSEcCtD
Metoprolol—Hypotension—Etoposide—sarcoma	0.000897	0.00167	CcSEcCtD
Metoprolol—Dizziness—Thiotepa—sarcoma	0.000884	0.00165	CcSEcCtD
Metoprolol—Hypersensitivity—Vincristine—sarcoma	0.000873	0.00163	CcSEcCtD
Metoprolol—Photosensitivity reaction—Epirubicin—sarcoma	0.000864	0.00161	CcSEcCtD
Metoprolol—Paraesthesia—Etoposide—sarcoma	0.000862	0.0016	CcSEcCtD
Metoprolol—Weight increased—Epirubicin—sarcoma	0.000861	0.0016	CcSEcCtD
Metoprolol—Dyspnoea—Etoposide—sarcoma	0.000856	0.00159	CcSEcCtD
Metoprolol—Somnolence—Etoposide—sarcoma	0.000853	0.00159	CcSEcCtD
Metoprolol—Angina pectoris—Doxorubicin—sarcoma	0.000853	0.00159	CcSEcCtD
Metoprolol—Hypersensitivity—Mitoxantrone—sarcoma	0.00085	0.00158	CcSEcCtD
Metoprolol—Asthenia—Vincristine—sarcoma	0.00085	0.00158	CcSEcCtD
Metoprolol—Vomiting—Thiotepa—sarcoma	0.00085	0.00158	CcSEcCtD
Metoprolol—Pneumonia—Epirubicin—sarcoma	0.000848	0.00158	CcSEcCtD
Metoprolol—Vomiting—Dactinomycin—sarcoma	0.000843	0.00157	CcSEcCtD
Metoprolol—Rash—Thiotepa—sarcoma	0.000842	0.00157	CcSEcCtD
Metoprolol—Dermatitis—Thiotepa—sarcoma	0.000842	0.00157	CcSEcCtD
Metoprolol—Headache—Thiotepa—sarcoma	0.000837	0.00156	CcSEcCtD
Metoprolol—Rash—Dactinomycin—sarcoma	0.000836	0.00156	CcSEcCtD
Metoprolol—Gastrointestinal disorder—Etoposide—sarcoma	0.000829	0.00154	CcSEcCtD
Metoprolol—Asthenia—Mitoxantrone—sarcoma	0.000828	0.00154	CcSEcCtD
Metoprolol—Fatigue—Etoposide—sarcoma	0.000827	0.00154	CcSEcCtD
Metoprolol—Jaundice—Epirubicin—sarcoma	0.000822	0.00153	CcSEcCtD
Metoprolol—Pain—Etoposide—sarcoma	0.000821	0.00153	CcSEcCtD
Metoprolol—Constipation—Etoposide—sarcoma	0.000821	0.00153	CcSEcCtD
Metoprolol—Conjunctivitis—Epirubicin—sarcoma	0.00082	0.00153	CcSEcCtD
Metoprolol—Diarrhoea—Vincristine—sarcoma	0.000811	0.00151	CcSEcCtD
Metoprolol—Sweating—Epirubicin—sarcoma	0.000809	0.00151	CcSEcCtD
Metoprolol—Photosensitivity reaction—Doxorubicin—sarcoma	0.000799	0.00149	CcSEcCtD
Metoprolol—Hepatobiliary disease—Epirubicin—sarcoma	0.000798	0.00149	CcSEcCtD
Metoprolol—Weight increased—Doxorubicin—sarcoma	0.000797	0.00148	CcSEcCtD
Metoprolol—Nausea—Thiotepa—sarcoma	0.000794	0.00148	CcSEcCtD
Metoprolol—Feeling abnormal—Etoposide—sarcoma	0.000791	0.00147	CcSEcCtD
Metoprolol—Diarrhoea—Mitoxantrone—sarcoma	0.00079	0.00147	CcSEcCtD
Metoprolol—Nausea—Dactinomycin—sarcoma	0.000788	0.00147	CcSEcCtD
Metoprolol—Agranulocytosis—Epirubicin—sarcoma	0.000787	0.00147	CcSEcCtD
Metoprolol—Pneumonia—Doxorubicin—sarcoma	0.000785	0.00146	CcSEcCtD
Metoprolol—Gastrointestinal pain—Etoposide—sarcoma	0.000785	0.00146	CcSEcCtD
Metoprolol—Dizziness—Vincristine—sarcoma	0.000784	0.00146	CcSEcCtD
Metoprolol—Bradycardia—Epirubicin—sarcoma	0.000771	0.00144	CcSEcCtD
Metoprolol—Urticaria—Etoposide—sarcoma	0.000762	0.00142	CcSEcCtD
Metoprolol—Jaundice—Doxorubicin—sarcoma	0.000761	0.00142	CcSEcCtD
Metoprolol—Rhinitis—Epirubicin—sarcoma	0.000759	0.00141	CcSEcCtD
Metoprolol—Abdominal pain—Etoposide—sarcoma	0.000759	0.00141	CcSEcCtD
Metoprolol—Body temperature increased—Etoposide—sarcoma	0.000759	0.00141	CcSEcCtD
Metoprolol—Conjunctivitis—Doxorubicin—sarcoma	0.000759	0.00141	CcSEcCtD
Metoprolol—Hepatitis—Epirubicin—sarcoma	0.000757	0.00141	CcSEcCtD
Metoprolol—Vomiting—Vincristine—sarcoma	0.000753	0.0014	CcSEcCtD
Metoprolol—Sweating—Doxorubicin—sarcoma	0.000748	0.00139	CcSEcCtD
Metoprolol—Rash—Vincristine—sarcoma	0.000747	0.00139	CcSEcCtD
Metoprolol—Dermatitis—Vincristine—sarcoma	0.000746	0.00139	CcSEcCtD
Metoprolol—Oedema peripheral—Epirubicin—sarcoma	0.000746	0.00139	CcSEcCtD
Metoprolol—Connective tissue disorder—Epirubicin—sarcoma	0.000744	0.00139	CcSEcCtD
Metoprolol—Headache—Vincristine—sarcoma	0.000742	0.00138	CcSEcCtD
Metoprolol—Hepatobiliary disease—Doxorubicin—sarcoma	0.000738	0.00137	CcSEcCtD
Metoprolol—Vomiting—Mitoxantrone—sarcoma	0.000734	0.00137	CcSEcCtD
Metoprolol—Visual impairment—Epirubicin—sarcoma	0.00073	0.00136	CcSEcCtD
Metoprolol—Agranulocytosis—Doxorubicin—sarcoma	0.000728	0.00136	CcSEcCtD
Metoprolol—Rash—Mitoxantrone—sarcoma	0.000728	0.00135	CcSEcCtD
Metoprolol—Dermatitis—Mitoxantrone—sarcoma	0.000727	0.00135	CcSEcCtD
Metoprolol—Headache—Mitoxantrone—sarcoma	0.000723	0.00135	CcSEcCtD
Metoprolol—Bradycardia—Doxorubicin—sarcoma	0.000713	0.00133	CcSEcCtD
Metoprolol—Eye disorder—Epirubicin—sarcoma	0.000708	0.00132	CcSEcCtD
Metoprolol—Hypersensitivity—Etoposide—sarcoma	0.000707	0.00132	CcSEcCtD
Metoprolol—Tinnitus—Epirubicin—sarcoma	0.000706	0.00131	CcSEcCtD
Metoprolol—Nausea—Vincristine—sarcoma	0.000704	0.00131	CcSEcCtD
Metoprolol—Cardiac disorder—Epirubicin—sarcoma	0.000703	0.00131	CcSEcCtD
Metoprolol—Rhinitis—Doxorubicin—sarcoma	0.000702	0.00131	CcSEcCtD
Metoprolol—Hepatitis—Doxorubicin—sarcoma	0.000701	0.0013	CcSEcCtD
Metoprolol—Oedema peripheral—Doxorubicin—sarcoma	0.00069	0.00129	CcSEcCtD
Metoprolol—Asthenia—Etoposide—sarcoma	0.000689	0.00128	CcSEcCtD
Metoprolol—Connective tissue disorder—Doxorubicin—sarcoma	0.000689	0.00128	CcSEcCtD
Metoprolol—Angiopathy—Epirubicin—sarcoma	0.000687	0.00128	CcSEcCtD
Metoprolol—Nausea—Mitoxantrone—sarcoma	0.000685	0.00128	CcSEcCtD
Metoprolol—Immune system disorder—Epirubicin—sarcoma	0.000684	0.00127	CcSEcCtD
Metoprolol—Mediastinal disorder—Epirubicin—sarcoma	0.000682	0.00127	CcSEcCtD
Metoprolol—Pruritus—Etoposide—sarcoma	0.000679	0.00126	CcSEcCtD
Metoprolol—Arrhythmia—Epirubicin—sarcoma	0.000677	0.00126	CcSEcCtD
Metoprolol—Visual impairment—Doxorubicin—sarcoma	0.000675	0.00126	CcSEcCtD
Metoprolol—Alopecia—Epirubicin—sarcoma	0.000669	0.00125	CcSEcCtD
Metoprolol—Mental disorder—Epirubicin—sarcoma	0.000663	0.00124	CcSEcCtD
Metoprolol—Diarrhoea—Etoposide—sarcoma	0.000657	0.00122	CcSEcCtD
Metoprolol—Eye disorder—Doxorubicin—sarcoma	0.000655	0.00122	CcSEcCtD
Metoprolol—Tinnitus—Doxorubicin—sarcoma	0.000653	0.00122	CcSEcCtD
Metoprolol—Cardiac disorder—Doxorubicin—sarcoma	0.00065	0.00121	CcSEcCtD
Metoprolol—Flatulence—Epirubicin—sarcoma	0.00065	0.00121	CcSEcCtD
Metoprolol—Tension—Epirubicin—sarcoma	0.000647	0.0012	CcSEcCtD
Metoprolol—Dysgeusia—Epirubicin—sarcoma	0.000646	0.0012	CcSEcCtD
Metoprolol—Nervousness—Epirubicin—sarcoma	0.00064	0.00119	CcSEcCtD
Metoprolol—Angiopathy—Doxorubicin—sarcoma	0.000636	0.00118	CcSEcCtD
Metoprolol—Dizziness—Etoposide—sarcoma	0.000635	0.00118	CcSEcCtD
Metoprolol—Muscle spasms—Epirubicin—sarcoma	0.000634	0.00118	CcSEcCtD
Metoprolol—Immune system disorder—Doxorubicin—sarcoma	0.000633	0.00118	CcSEcCtD
Metoprolol—Mediastinal disorder—Doxorubicin—sarcoma	0.000631	0.00118	CcSEcCtD
Metoprolol—Arrhythmia—Doxorubicin—sarcoma	0.000626	0.00117	CcSEcCtD
Metoprolol—Vision blurred—Epirubicin—sarcoma	0.000621	0.00116	CcSEcCtD
Metoprolol—Alopecia—Doxorubicin—sarcoma	0.000619	0.00115	CcSEcCtD
Metoprolol—Mental disorder—Doxorubicin—sarcoma	0.000614	0.00114	CcSEcCtD
Metoprolol—Vomiting—Etoposide—sarcoma	0.00061	0.00114	CcSEcCtD
Metoprolol—Rash—Etoposide—sarcoma	0.000605	0.00113	CcSEcCtD
Metoprolol—Dermatitis—Etoposide—sarcoma	0.000605	0.00113	CcSEcCtD
Metoprolol—Headache—Etoposide—sarcoma	0.000601	0.00112	CcSEcCtD
Metoprolol—Flatulence—Doxorubicin—sarcoma	0.000601	0.00112	CcSEcCtD
Metoprolol—Tension—Doxorubicin—sarcoma	0.000599	0.00111	CcSEcCtD
Metoprolol—Dysgeusia—Doxorubicin—sarcoma	0.000597	0.00111	CcSEcCtD
Metoprolol—Nervousness—Doxorubicin—sarcoma	0.000592	0.0011	CcSEcCtD
Metoprolol—Vertigo—Epirubicin—sarcoma	0.000592	0.0011	CcSEcCtD
Metoprolol—Syncope—Epirubicin—sarcoma	0.000591	0.0011	CcSEcCtD
Metoprolol—Leukopenia—Epirubicin—sarcoma	0.00059	0.0011	CcSEcCtD
Metoprolol—Muscle spasms—Doxorubicin—sarcoma	0.000586	0.00109	CcSEcCtD
Metoprolol—Palpitations—Epirubicin—sarcoma	0.000583	0.00108	CcSEcCtD
Metoprolol—Loss of consciousness—Epirubicin—sarcoma	0.000579	0.00108	CcSEcCtD
Metoprolol—Vision blurred—Doxorubicin—sarcoma	0.000575	0.00107	CcSEcCtD
Metoprolol—Nausea—Etoposide—sarcoma	0.00057	0.00106	CcSEcCtD
Metoprolol—Hypertension—Epirubicin—sarcoma	0.000569	0.00106	CcSEcCtD
Metoprolol—Arthralgia—Epirubicin—sarcoma	0.000561	0.00105	CcSEcCtD
Metoprolol—Chest pain—Epirubicin—sarcoma	0.000561	0.00105	CcSEcCtD
Metoprolol—Anxiety—Epirubicin—sarcoma	0.000559	0.00104	CcSEcCtD
Metoprolol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.000557	0.00104	CcSEcCtD
Metoprolol—Dry mouth—Epirubicin—sarcoma	0.000549	0.00102	CcSEcCtD
Metoprolol—Vertigo—Doxorubicin—sarcoma	0.000548	0.00102	CcSEcCtD
Metoprolol—Syncope—Doxorubicin—sarcoma	0.000547	0.00102	CcSEcCtD
Metoprolol—Leukopenia—Doxorubicin—sarcoma	0.000546	0.00102	CcSEcCtD
Metoprolol—Confusional state—Epirubicin—sarcoma	0.000542	0.00101	CcSEcCtD
Metoprolol—Palpitations—Doxorubicin—sarcoma	0.000539	0.001	CcSEcCtD
Metoprolol—Oedema—Epirubicin—sarcoma	0.000538	0.001	CcSEcCtD
Metoprolol—Loss of consciousness—Doxorubicin—sarcoma	0.000536	0.000998	CcSEcCtD
Metoprolol—Shock—Epirubicin—sarcoma	0.000529	0.000986	CcSEcCtD
Metoprolol—Nervous system disorder—Epirubicin—sarcoma	0.000528	0.000983	CcSEcCtD
Metoprolol—Thrombocytopenia—Epirubicin—sarcoma	0.000527	0.000981	CcSEcCtD
Metoprolol—Hypertension—Doxorubicin—sarcoma	0.000527	0.000981	CcSEcCtD
Metoprolol—Tachycardia—Epirubicin—sarcoma	0.000525	0.000978	CcSEcCtD
Metoprolol—Skin disorder—Epirubicin—sarcoma	0.000523	0.000973	CcSEcCtD
Metoprolol—Hyperhidrosis—Epirubicin—sarcoma	0.00052	0.000969	CcSEcCtD
Metoprolol—Chest pain—Doxorubicin—sarcoma	0.000519	0.000967	CcSEcCtD
Metoprolol—Arthralgia—Doxorubicin—sarcoma	0.000519	0.000967	CcSEcCtD
Metoprolol—Anxiety—Doxorubicin—sarcoma	0.000517	0.000964	CcSEcCtD
Metoprolol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.000516	0.00096	CcSEcCtD
Metoprolol—Dry mouth—Doxorubicin—sarcoma	0.000508	0.000946	CcSEcCtD
Metoprolol—Hypotension—Epirubicin—sarcoma	0.000503	0.000936	CcSEcCtD
Metoprolol—Confusional state—Doxorubicin—sarcoma	0.000502	0.000935	CcSEcCtD
Metoprolol—Oedema—Doxorubicin—sarcoma	0.000498	0.000927	CcSEcCtD
Metoprolol—Musculoskeletal discomfort—Epirubicin—sarcoma	0.00049	0.000913	CcSEcCtD
Metoprolol—Shock—Doxorubicin—sarcoma	0.00049	0.000912	CcSEcCtD
Metoprolol—Nervous system disorder—Doxorubicin—sarcoma	0.000488	0.000909	CcSEcCtD
Metoprolol—Thrombocytopenia—Doxorubicin—sarcoma	0.000487	0.000908	CcSEcCtD
Metoprolol—Insomnia—Epirubicin—sarcoma	0.000487	0.000906	CcSEcCtD
Metoprolol—Tachycardia—Doxorubicin—sarcoma	0.000486	0.000905	CcSEcCtD
Metoprolol—Skin disorder—Doxorubicin—sarcoma	0.000484	0.0009	CcSEcCtD
Metoprolol—Paraesthesia—Epirubicin—sarcoma	0.000483	0.0009	CcSEcCtD
Metoprolol—Hyperhidrosis—Doxorubicin—sarcoma	0.000481	0.000896	CcSEcCtD
Metoprolol—Dyspnoea—Epirubicin—sarcoma	0.00048	0.000893	CcSEcCtD
Metoprolol—Somnolence—Epirubicin—sarcoma	0.000478	0.000891	CcSEcCtD
Metoprolol—Dyspepsia—Epirubicin—sarcoma	0.000474	0.000882	CcSEcCtD
Metoprolol—Hypotension—Doxorubicin—sarcoma	0.000465	0.000866	CcSEcCtD
Metoprolol—Gastrointestinal disorder—Epirubicin—sarcoma	0.000464	0.000865	CcSEcCtD
Metoprolol—Fatigue—Epirubicin—sarcoma	0.000464	0.000864	CcSEcCtD
Metoprolol—Constipation—Epirubicin—sarcoma	0.00046	0.000857	CcSEcCtD
Metoprolol—Pain—Epirubicin—sarcoma	0.00046	0.000857	CcSEcCtD
Metoprolol—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000454	0.000845	CcSEcCtD
Metoprolol—Insomnia—Doxorubicin—sarcoma	0.00045	0.000838	CcSEcCtD
Metoprolol—Paraesthesia—Doxorubicin—sarcoma	0.000447	0.000832	CcSEcCtD
Metoprolol—Dyspnoea—Doxorubicin—sarcoma	0.000444	0.000826	CcSEcCtD
Metoprolol—Feeling abnormal—Epirubicin—sarcoma	0.000443	0.000826	CcSEcCtD
Metoprolol—Somnolence—Doxorubicin—sarcoma	0.000443	0.000824	CcSEcCtD
Metoprolol—Gastrointestinal pain—Epirubicin—sarcoma	0.00044	0.000819	CcSEcCtD
Metoprolol—Dyspepsia—Doxorubicin—sarcoma	0.000438	0.000816	CcSEcCtD
Metoprolol—Gastrointestinal disorder—Doxorubicin—sarcoma	0.00043	0.0008	CcSEcCtD
Metoprolol—Fatigue—Doxorubicin—sarcoma	0.000429	0.000799	CcSEcCtD
Metoprolol—Urticaria—Epirubicin—sarcoma	0.000427	0.000796	CcSEcCtD
Metoprolol—Constipation—Doxorubicin—sarcoma	0.000426	0.000793	CcSEcCtD
Metoprolol—Pain—Doxorubicin—sarcoma	0.000426	0.000793	CcSEcCtD
Metoprolol—Abdominal pain—Epirubicin—sarcoma	0.000425	0.000792	CcSEcCtD
Metoprolol—Body temperature increased—Epirubicin—sarcoma	0.000425	0.000792	CcSEcCtD
Metoprolol—Feeling abnormal—Doxorubicin—sarcoma	0.00041	0.000764	CcSEcCtD
Metoprolol—Gastrointestinal pain—Doxorubicin—sarcoma	0.000407	0.000758	CcSEcCtD
Metoprolol—Hypersensitivity—Epirubicin—sarcoma	0.000396	0.000738	CcSEcCtD
Metoprolol—Urticaria—Doxorubicin—sarcoma	0.000395	0.000736	CcSEcCtD
Metoprolol—Body temperature increased—Doxorubicin—sarcoma	0.000394	0.000733	CcSEcCtD
Metoprolol—Abdominal pain—Doxorubicin—sarcoma	0.000394	0.000733	CcSEcCtD
Metoprolol—Asthenia—Epirubicin—sarcoma	0.000386	0.000719	CcSEcCtD
Metoprolol—Pruritus—Epirubicin—sarcoma	0.000381	0.000709	CcSEcCtD
Metoprolol—Diarrhoea—Epirubicin—sarcoma	0.000368	0.000685	CcSEcCtD
Metoprolol—Hypersensitivity—Doxorubicin—sarcoma	0.000367	0.000683	CcSEcCtD
Metoprolol—Asthenia—Doxorubicin—sarcoma	0.000357	0.000665	CcSEcCtD
Metoprolol—Dizziness—Epirubicin—sarcoma	0.000356	0.000663	CcSEcCtD
Metoprolol—Pruritus—Doxorubicin—sarcoma	0.000352	0.000656	CcSEcCtD
Metoprolol—Vomiting—Epirubicin—sarcoma	0.000342	0.000637	CcSEcCtD
Metoprolol—Diarrhoea—Doxorubicin—sarcoma	0.000341	0.000634	CcSEcCtD
Metoprolol—Rash—Epirubicin—sarcoma	0.000339	0.000632	CcSEcCtD
Metoprolol—Dermatitis—Epirubicin—sarcoma	0.000339	0.000631	CcSEcCtD
Metoprolol—Headache—Epirubicin—sarcoma	0.000337	0.000628	CcSEcCtD
Metoprolol—Dizziness—Doxorubicin—sarcoma	0.000329	0.000613	CcSEcCtD
Metoprolol—Nausea—Epirubicin—sarcoma	0.00032	0.000595	CcSEcCtD
Metoprolol—Vomiting—Doxorubicin—sarcoma	0.000317	0.000589	CcSEcCtD
Metoprolol—Rash—Doxorubicin—sarcoma	0.000314	0.000584	CcSEcCtD
Metoprolol—Dermatitis—Doxorubicin—sarcoma	0.000314	0.000584	CcSEcCtD
Metoprolol—Headache—Doxorubicin—sarcoma	0.000312	0.000581	CcSEcCtD
Metoprolol—Nausea—Doxorubicin—sarcoma	0.000296	0.000551	CcSEcCtD
